BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $478M (95.0% shares, 5.0% debt)

Holdings (30)

— ARRAY BIOPHARMA INC 14.5%

Value $69.32M Shares 9,405,817 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 13.1%

Value $62.69M Shares 8,303,084 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 7.3%

Value $34.74M Shares 2,171,108 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 7.0%

Value $33.35M Shares 1,177,481 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 6.9%

Value $33.1M Shares 1,284,115 Est. Cost — Unrealized —

— EXELIXIS INC 5.0%

Value $23.94M Shares 31,239,000 Est. Cost — Unrealized —

— ONCOTHYREON INC 4.9%

Value $23.33M Shares 14,314,178 Est. Cost — Unrealized —

LGND LIGAND PHARMACEUTICALS INC 4.3%

Value $20.59M Shares 267,090 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 4.2%

Value $20.3M Shares 1,340,659 Est. Cost — Unrealized —

— TARGACEPT INC 4.1%

Value $19.77M Shares 6,655,128 Est. Cost — Unrealized —

— VITAE PHARMACEUTICALS INC 3.9%

Value $18.47M Shares 1,577,435 Est. Cost — Unrealized —

— QLT INC 3.4%

Value $16.23M Shares 4,149,862 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 3.0%

Value $14.29M Shares 2,106,989 Est. Cost — Unrealized —

— LOXO ONCOLOGY INC 2.9%

Value $14.02M Shares 1,125,665 Est. Cost — Unrealized —

— ARQULE INC 2.9%

Value $13.83M Shares 6,174,561 Est. Cost — Unrealized —

EXEL EXELIXIS INC 2.7%

Value $12.82M Shares 4,988,357 Est. Cost — Unrealized —

— FIVE PRIME THERAPEUTICS INC 2.4%

Value $11.49M Shares 502,832 Est. Cost — Unrealized —

— GTX INC DEL 1.6%

Value $7.508M Shares 11,111,111 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 1.4%

Value $6.601M Shares 391,424 Est. Cost — Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.0%

Value $4.638M Shares 1,893,030 Est. Cost — Unrealized —

— MAST THERAPEUTICS INC 0.7%

Value $3.512M Shares 7,241,600 Est. Cost — Unrealized —

— BIOLINERX LTD 0.7%

Value $3.167M Shares 1,501,000 Est. Cost — Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.6%

Value $2.942M Shares 1,368,500 Est. Cost — Unrealized —

— REGADO BIOSCIENCES INC 0.5%

Value $2.297M Shares 1,882,521 Est. Cost — Unrealized —

— ACHAOGEN INC 0.3%

Value $1.333M Shares 136,600 Est. Cost — Unrealized —

— MEI PHARMA INC 0.2%

Value $1.074M Shares 600,000 Est. Cost — Unrealized —

— APTOSE BIOSCIENCES INC 0.2%

Value $907K Shares 166,664 Est. Cost — Unrealized —

— BIOTA PHARMACEUTIALS INC 0.2%

Value $807K Shares 350,776 Est. Cost — Unrealized —

— SOPHIRIS BIO INC 0.1%

Value $614K Shares 1,060,283 Est. Cost — Unrealized —

— KALOBIOS PHARMACEUTICALS INC 0.1%

Value $569K Shares 1,162,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ARRAY BIOPHARMA INC	9,405,817	$69.32M	14.5%	—	—	COM	04269X105
—	CHEMOCENTRYX INC	8,303,084	$62.69M	13.1%	—	—	COM	16383L106
IRWD	IRONWOOD PHARMACEUTICALS INC	2,171,108	$34.74M	7.3%	—	—	COM CL A	46333X108
—	FORWARD PHARMA A/S	1,177,481	$33.35M	7.0%	—	—	SPONSORED ADR	34986J105
—	ONCOMED PHARMACEUTICALS INC	1,284,115	$33.1M	6.9%	—	—	COM	68234X102
—	EXELIXIS INC	31,239,000	$23.94M	5.0%	—	—	NOTE 4.250% 8/1	30161QAC8
—	ONCOTHYREON INC	14,314,178	$23.33M	4.9%	—	—	COM	682324108
LGND	LIGAND PHARMACEUTICALS INC	267,090	$20.59M	4.3%	—	—	COM NEW	53220K504
—	CONCERT PHARMACEUTICALS INC	1,340,659	$20.3M	4.2%	—	—	COM	206022105
—	TARGACEPT INC	6,655,128	$19.77M	4.1%	—	—	COM	87611R306
—	VITAE PHARMACEUTICALS INC	1,577,435	$18.47M	3.9%	—	—	COM	92847N103
—	QLT INC	4,149,862	$16.23M	3.4%	—	—	COM	746927102
CYTK	CYTOKINETICS INC	2,106,989	$14.29M	3.0%	—	—	COM NEW	23282W605
—	LOXO ONCOLOGY INC	1,125,665	$14.02M	2.9%	—	—	COM	548862101
—	ARQULE INC	6,174,561	$13.83M	2.9%	—	—	COM	04269E107
EXEL	EXELIXIS INC	4,988,357	$12.82M	2.7%	—	—	COM	30161Q104
—	FIVE PRIME THERAPEUTICS INC	502,832	$11.49M	2.4%	—	—	COM	33830X104
—	GTX INC DEL	11,111,111	$7.508M	1.6%	—	—	COM	40052B108
XENE	XENON PHARMACEUTICALS INC	391,424	$6.601M	1.4%	—	—	COM	98420N105
—	SUNESIS PHARMACEUTICALS INC	1,893,030	$4.638M	1.0%	—	—	COM NEW	867328601
—	MAST THERAPEUTICS INC	7,241,600	$3.512M	0.7%	—	—	COM	576314108
—	BIOLINERX LTD	1,501,000	$3.167M	0.7%	—	—	SPONSORED ADR	09071M106
—	ONCOGENEX PHARMACEUTICALS IN	1,368,500	$2.942M	0.6%	—	—	COM	68230A106
—	REGADO BIOSCIENCES INC	1,882,521	$2.297M	0.5%	—	—	COM	75874Q107
—	ACHAOGEN INC	136,600	$1.333M	0.3%	—	—	COM	004449104
—	MEI PHARMA INC	600,000	$1.074M	0.2%	—	—	COM NEW	55279B202
—	APTOSE BIOSCIENCES INC	166,664	$907K	0.2%	—	—	COM NEW	03835T200
—	BIOTA PHARMACEUTIALS INC	350,776	$807K	0.2%	—	—	COM	090694100
—	SOPHIRIS BIO INC	1,060,283	$614K	0.1%	—	—	COM NEW	83578Q209
—	KALOBIOS PHARMACEUTICALS INC	1,162,000	$569K	0.1%	—	—	COM	48344T100